¼¼°èÀÇ È÷¾Ë·ç·Ð»ê °üÀý³» º¸Ãæ ¿ä¹ý ½ÃÀå : ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м®(2025-2031³â) - MedCore
Hyaluronic Acid Viscosupplementation Market Size, Share, and Trends Analysis | Global | 2025-2031 | MedCore | Includes: Single Injection Market, Two Injection Market, and 2 more
»óǰÄÚµå : 1676627
¸®¼­Ä¡»ç : iData Research Inc.
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 60 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,995 £Ü 7,052,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,995 £Ü 9,876,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,995 £Ü 12,700,000
PDF (Corporate License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷(ÇØ¿Ü)ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ È÷¾Ë·ç·Ð»ê(HA) °üÀý³» º¸Ãæ ¿ä¹ý ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 25¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÀÌ ½ÃÀåÀº 2.9%ÀÇ CAGR·Î È®´ëÇϸç, 2031³â¿¡´Â 30¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

COVID-19 ÆÒµ¥¹ÍÀ¸·Î ÀÎÇØ ¼±ÅÃÀû ¼ö¼úÀÌ ¿¬±âµÇ¸é¼­ ¸ÅÃâÀÌ ÀϽÃÀûÀ¸·Î °¨¼ÒÇß½À´Ï´Ù. ±×·¯³ª 2022³â±îÁö ½ÃÀåÀÌ È¸º¹µÇ¾î ¾ÈÁ¤ÀûÀÎ ¼ºÀå¼¼·Î µ¹¾Æ¼¹½À´Ï´Ù.

°í·ÉÈ­ Àα¸ Áõ°¡¿Í °ñ°üÀý¿° ȯÀÚ Áõ°¡´Â °üÀý³» ġȯ¼ú¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

¼¼°èÀÇ È÷¾Ë·ç·Ð»ê °üÀý³» º¸Ãæ ¿ä¹ý ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀåÀÇ °³¿ä¿Í ½ÃÀå ºÐ¼®°ú ¿¹Ãø, ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ, °æÀï ±¸µµ µîÀ» Á¦°øÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

°³¿ä

¼­·Ð

½Ã¼ú °Ç¼ö

½ÃÀå °³¿ä

½ÃÀå ºÐ¼®°ú ¿¹Ãø

ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎ

°æÀï ½ÃÀå Á¡À¯À² ºÐ¼®

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global hyaluronic acid (HA) viscosupplementation market was valued at $2.5 billion in 2024 and is projected to grow at a CAGR of 2.9%, reaching $3 billion by 2031.

This market includes four primary product categories:

Market Insights & Data Coverage

Market Trends

Impact of COVID-19 on Market Growth:

* The COVID-19 pandemic led to a temporary decline in sales due to postponements of elective procedures.

* By 2022, the market rebounded, returning to steady growth.

* Increased aging population and rising osteoarthritis cases are fueling demand for HA viscosupplementation.

* Convenience and lower patient burden are driving single-injection adoption.

Market Share Insights

Top Competitors in the Global Hyaluronic Acid Viscosupplementation Market (2024):

1 DePuy Synthes

* Market leader with its MONOVISC(R) (single-injection) and ORTHOVISC(R) (three-injection) products.

2 Fidia

* Second-largest market share with its HYMOVIS(R) (two-injection therapy).

3 Sanofi

* Third-largest competitor, offering Synvisc(R) and Synvisc-One(R), benefiting from the growing osteoarthritis market.

Market Segmentation Summary

Hyaluronic Acid Viscosupplementation Market

Global Research Scope

* North America (U.S., Canada)

* Latin America (Brazil, Mexico, Argentina, Colombia, Chile)

* Western Europe (Germany, France, U.K., Spain, Italy)

* Central & Eastern Europe (Poland, Russia, Turkey, Hungary)

* Middle East (Saudi Arabia, UAE, Israel)

* Asia Pacific (China, Japan, India, South Korea, Australia)

* Africa (South Africa, Egypt, Nigeria, Kenya)

Quantitative Coverage

Qualitative Coverage

Data Sources:

TABLE OF CONTENT

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â